CTLA-4 and not CD28 is a susceptibility gene for thyroid autoantibody production

被引:123
|
作者
Tomer, Y
Greenberg, DA
Barbesino, G
Concepcion, E
Davies, TF
机构
[1] CUNY Mt Sinai Sch Med, Dept Med, Div Endocrinol & Metab, New York, NY 10029 USA
[2] CUNY Mt Sinai Sch Med, Dept Psychiat, Div Endocrinol & Metab, New York, NY 10029 USA
[3] CUNY Mt Sinai Sch Med, Dept Biomath, Div Endocrinol & Metab, New York, NY 10029 USA
来源
关键词
D O I
10.1210/jc.86.4.1687
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
One of the hallmarks of the human autoimmune thyroid diseases (AITDs) is the production of high titers of autoantibodies against thyroglobulin and thyroid peroxidase that often precedes the development of clinical disease. A high percentage of family members of patients with AITDs have significant titers of thyroid antibodies (TAbs), suggesting a genetic predisposition for their development, and segregation analyses have favored a dominant mode of inheritance. The aim of the present study was to identify the susceptibility genes for TAb production. We completed a genome-wide scan in 56 multiplex families (323 individuals) in which all family members with AITDs and/or detectable TAbs were considered affected. The highest a-point logarithm of odds (LOD) score of 3.6 was obtained for marker D2S325 on chromosome 2q33 at 210.9 centimorgans. This locus showed no evidence for linkage to Graves' disease or Hashimoto's thyroiditis (2-point LOD scores, 0.42 for Graves' disease and -0.60 for Hashimoto's thyroiditis), demonstrating that the gene in this region conferred susceptibility to TAbs, but that clinical disease development required additional genetic and/or environmental factors. We then fine-mapped the region linked with TAbs using 11 densely spaced microsatellite markers. Multipoint linkage analysis using these markers showed a maximum LOD score of 4.2 obtained for marker D2S155 at 209.8 centimorgans (with heterogeneity, alpha = 0.41). As the linked region contained the CTLA-4 and CD28 genes, we then tested whether they mere the susceptibility genes for TAbs on chromosome 2q33. The CD28 gene was sequenced in 15 individuals, and a new C/T single nucleotide polymorphism (SNP) was identified in intron 3. Analysis of this SNP revealed no association with TAbs in the probands of the linked families (families that were linked with D2S155) compared with controls. The CTLA-4 gene was analyzed using the known A/G(49) SNP, and the results showed a significantly increased frequency of the G allele in the probands of the linked families compared with the probands of the unlinked families or with controls (P = 0.02). We concluded that 1) a major gene for thyroid autoantibody production was located on chromosome 2q33; 2) the TAb gene on chromosome 2q33 was most likely the CTLA-4 gene and not the CD28 gene; and 3) CTLA-4 contributed to the genetic susceptibility to TAb production, but there was no evidence that it contributed specifically to Graves' or Hashimoto's diseases.
引用
收藏
页码:1687 / 1693
页数:7
相关论文
共 50 条
  • [41] CD28/CTLA-4/ICOS haplotypes confers susceptibility to Graves' disease and modulates clinical phenotype of disease
    Pawlak-Adamska, Edyta
    Frydecka, Irena
    Bolanowski, Marek
    Tomkiewicz, Anna
    Jonkisz, Anna
    Karabon, Lidia
    Partyka, Anna
    Nowak, Oskar
    Szalinski, Marek
    Daroszewski, Jacek
    ENDOCRINE, 2017, 55 (01) : 186 - 199
  • [42] CD28/CTLA-4及其配体的研究进展
    刘慧萍
    张远强
    李恩善
    解剖科学进展, 1997, (01) : 62 - 66
  • [43] Fine-mapping of an increased total IgE susceptibility gene on chromosome 2q: Analysis of CTLA-4 and CD28
    Howard, TD
    Postma, DS
    Hawkins, GA
    Koppelman, GH
    Zheng, SQL
    Xu, JF
    Meyers, DA
    Bleecker, ER
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2002, 109 (01) : S174 - S174
  • [44] The effect of CTLA-4 and CD28 gene variants and circulating protein levels in patients with gastric cancer
    Arikan, Soykan
    Gumus, Alper
    Kucukhuseyin, Ozlem
    Coskun, Cihan
    Turan, Saime
    Cacina, Canan
    Talu, Canan Kelten
    Akyuz, Filiz
    Farooqi, Ammad Ahmad
    Kiran, Bayram
    Yaylim, Ilhan
    TURKISH JOURNAL OF BIOCHEMISTRY-TURK BIYOKIMYA DERGISI, 2017, 42 (05): : 551 - 558
  • [45] Influence of CTLA-4/CD28/ICOS gene polymorphisms on the susceptibility to cervical squamous cell carcinoma and stage of differentiation in the Polish population
    Pawlak, Edyta
    Karabon, Lidia
    Wlodarska-Polinska, Iwona
    Jedynak, Anna
    Jonkisz, Anna
    Tomkiewicz, Anna
    Kornafel, Jan
    Stepien, Marcin
    Ignatowicz, Agnieszka
    Lebioda, Arleta
    Dobosz, Tadeusz
    Frydecka, Irena
    HUMAN IMMUNOLOGY, 2010, 71 (02) : 195 - 200
  • [46] Association of CTLA-4 and CD28 Gene Polymorphisms with Type 1 Diabetes in South Indian Population
    Gunavathy, Nagarajan
    Asirvatham, Arthur
    Chitra, Ayyappan
    Jayalakshmi, Mariakuttikan
    IMMUNOLOGICAL INVESTIGATIONS, 2019, 48 (06) : 659 - 671
  • [47] CD28/CTLA-4/ICOS haplotypes confers susceptibility to Graves’ disease and modulates clinical phenotype of disease
    Edyta Pawlak-Adamska
    Irena Frydecka
    Marek Bolanowski
    Anna Tomkiewicz
    Anna Jonkisz
    Lidia Karabon
    Anna Partyka
    Oskar Nowak
    Marek Szalinski
    Jacek Daroszewski
    Endocrine, 2017, 55 : 186 - 199
  • [48] A NOVEL FULLY HUMAN CD28 ANTIBODY THAT CROSSREACTS WITH CTLA-4 AND MOUSE CD28 FOR POTENTIAL APPLICATIONS IN CANCER IMMUNOTHERAPY
    Elsayed, Abdullah
    Peissert, Frederik
    Pluss, Louis
    Ulrich, Franziska
    Puca, Emanuele
    De Luca, Roberto
    Halin, Cornelia
    Neri, Dario
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A1116 - A1116
  • [49] CTLA-4 augments internalization and degradation of CD28 in CD8+T cells
    Berg, M
    Zavazava, N
    FASEB JOURNAL, 2005, 19 (04): : A908 - A908
  • [50] CD28/CTLA-4 and CD80/CD86 families - Signaling and function
    Slavik, JM
    Hutchcroft, JE
    Bierer, BE
    IMMUNOLOGIC RESEARCH, 1999, 19 (01) : 1 - 24